Status:
UNKNOWN
Breast Cancer Endocrine Therapy FITness (BE-FIT) Trial.
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
British Columbia Cancer Agency
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
19-75 years
Phase:
NA
Brief Summary
This project will assess the efficacy of an 8-week virtual exercise program on physical function offered to those with a breast cancer diagnosis currently receiving endocrine therapy. The intervention...
Detailed Description
Purpose: The purpose of this study is to test the effect of a virtually delivered supervised exercise program specific to breast cancer survivors on endocrine therapy versus delayed exercise in a part...
Eligibility Criteria
Inclusion
- Stage I - III breast cancer patients who are treated with curative intent
- Completed primary treatment, including surgery, radiation therapy and/or chemotherapy
- Currently receiving adjuvant endocrine therapy (Tamoxifen or an Aromatase Inhibitor) for at least 3 months (to allow for acclimatization) and within 3-years of of staring endocrine therapy.
- Can read and speak English
- Has access to a tablet, smartphone, laptop or computer with built-in video camera
Exclusion
- Not currently receiving endocrine therapy or scheduled to stop within 6 months
- Diagnosed with stage IV breast cancer
- Not willing to attend a twice-weekly exercise program virtually for the duration of the study.
- Not willing to comply with safety measures of virtual programming (to be seen on camera and monitored via video by the instructor)
Key Trial Info
Start Date :
March 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT04824339
Start Date
March 15 2021
End Date
December 31 2023
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Exercise Physiology Lab
Vancouver, British Columbia, Canada, V6T 1Z3